ライフサイエンスコーパス: spirometry

1 COPD and 26 with chronic bronchitis (normal spirometry).

2 uninfected participants was determined using spirometry.

3 ion of previous chest CT findings and normal spirometry.

4 Lung function was assessed by spirometry.

5 y adopted technical standards for conducting spirometry.

6 No safety concerns were associated with spirometry.

7 iratory volume in 1 s (FEV1) was measured by spirometry.

8 ation of reversible airway obstruction using spirometry.

9 nt prebronchodilator and post-bronchodilator spirometry.

10 Study, we examined 7,225 with COPD based on spirometry.

11 Lung function was assessed using spirometry.

12 rs and instruction on how to self-administer spirometry.

13 ymptoms were invited for post-bronchodilator spirometry.

14 tionnaires and lung function was measured by spirometry.

15 ed with hospital-based and weekly home-based spirometry.

16 previously identified in analyses of COPD or spirometry.

17 F%p) from baseline to week 52, measured with spirometry.

18 determination of carbon monoxide uptake and spirometry.

19 olume loops, and at 10 and 16 years by using spirometry.

20 performance and interpretation of workplace spirometry.

21 chest radiography, only 2296 (33%) also had spirometry.

22 Lung function was measured by spirometry.

23 tion associated with stable and/or improving spirometry.

24 inhomogeneity with greater sensitivity than spirometry.

25 rch were found to have good correlation with spirometry.

26 seline over 24 weeks, measured by daily home spirometry.

27 bumin-induced asthma model by using invasive spirometry.

28 rn was higher than that in those with normal spirometry (12.4% [35/282] vs. 6.0% [24/399], P = 0.003)

29 (diet, exercise, blood pressure monitoring, spirometry), 13%-23% for immunosuppressants and other me

30 onse to bronchodilator inhalation (58%) than spirometry (33%).

31 uality-of-life assessments, polysomnography, spirometry, 6-minute-walk distance, dropouts, compliance

32 Repeated spirometry, 6MWD, and peripheral blood T-cell cytokine r

33 types remained normal for GLI-defined normal spirometry across GOLD spirometric categories.

34 The larger dimensionality of 3D MR Spirometry advantageously allows the extraction of origi

35 acity (FVC) of less than 0.70 as assessed by spirometry after bronchodilator use.

36 etermination has been limited by reliance on spirometry alone to assess disease severity in predomina

37 e of onset and duration of symptoms, and (i) spirometry and (ii) small airway involvement measured by

38 Clinical history, spirometry and blood samples were obtained from pigeon f

39 Spirometry and bronchodilator testing were done at basel

40 Spirometry and chest high-resolution computed tomographi

41 health survey that included a questionnaire, spirometry and clinical examination by a physician blind

42 12, and 18 months (respiratory symptoms) and spirometry and CO (ppm) in exhaled breath measurements.

43 expectedly present in ex-smokers with normal spirometry and CT findings.

44 ficients (ICCs), and their associations with spirometry and CT measurements of 15th percentile attenu

45 reference sources are updated with data for spirometry and diffusing capacity published since prior

46 Spirometry and full-lung CT-derived measures of total lu

47 Subjects performed spirometry and had fraction of exhaled nitric oxide valu

48 Spirometry and health status (as assessed by St.

49 (FEV(1)) reversibility Materials and Methods Spirometry and hyperpolarized (3)He MRI were evaluated i

50 nd prebronchodilator and post-bronchodilator spirometry and hyperpolarized (3)He MRI.

51 vessels in 2014-2017 with postbronchodilator spirometry and inspiratory chest CT to quantify percent

52 ciated with AR2 that were not discernible by spirometry and is useful for graft monitoring after a lu

53 rican Thoracic Society guidelines using both spirometry and lung volumes.

54 We studied 3851 subjects who underwent spirometry and methacholine challenge tests both at base

55 s without respiratory diseases who underwent spirometry and MostGraph-01 from January to October 2014

56 ing history, >/=10 pack-years), we evaluated spirometry and multiple phenotypes, including dyspnea se

57 roved HIPAA-compliant protocol and underwent spirometry and plethysmography, completed the St George'

58 Patients are monitored with spirometry and routine surveillance transbronchial biops

59 unction and atopic status were determined by spirometry and skin prick testing.

60 Weekly outpatient oscillometry and spirometry and surveillance biopsies at Weeks 6 and 12 w

61 ection of pulmonary exacerbations using home spirometry and symptom monitoring would result in slower

62 arly intervention arm subjects measured home spirometry and symptoms electronically twice per week.

63 Screening spirometry and tests of diffusing capacity might be bene

64 of bronchodilator response measured by using spirometry and the global imaging metric percentage vent

65 healthy patients who did not smoke underwent spirometry and two separate 1.5-T MR imaging examination

66 val) adults with persistent asthma underwent spirometry and were administered the A-IQOLS, other asth

67 participate, of whom 588 provided acceptable spirometry and were analysed.

68 Communities study participants who underwent spirometry and were asked about lung health (1987-1989)

69 measured lung function (plethysmography and spirometry) and airway hyper-reactivity (AHR; methacholi

70 ymptoms, rescue medication use, and baseline spirometry) and morbidity (school absences and unschedul

71 lth-related quality-of-life assessments, the spirometry, and 6-minute-walk distance results improved

72 en of chronic respiratory symptoms, abnormal spirometry, and air pollution exposures in adults in rur

73 ed using the Asthma Control Questionnaire-5, spirometry, and biomarker measurements (Fe(NO) and perip

74 oup and control subjects had symptom scores, spirometry, and bronchoalveolar lavage before and after

75 ulse oximetry (SpO(2) ), arterial blood gas, spirometry, and contrast-enhanced echocardiography (CE).

76 inistered to participants, chest tomography, spirometry, and examination of induced sputum.

77 connective tissue disease (CTD) serologies, spirometry, and high-resolution computed tomography ches

78 CMV viral load, serologies, serial spirometry, and mortality were recorded from medical rec

79 hronic obstructive pulmonary disease, normal spirometry, and normal airways responsiveness, and had s

80 ratory Health Survey provided serum samples, spirometry, and questionnaire data about respiratory and

81 with home peak flow and symptom monitoring, spirometry, and serial bronchial challenge tests, and th

82 g Initiative (GLI-2012) reference values for spirometry are appropriate for children in sub-Saharan A

83 Important aspects of workplace spirometry are discussed and recommendations are provide

84 RATIONALE: Accurate reference values for spirometry are important because the results are used fo

85 Computed tomography (CT) and spirometry are the mainstays of clinical pulmonary asses

86 Most studies have used spirometry as the primary assessment of airway obstructi

87 ealed from the researchers who performed the spirometry assessments.

88 a on clinical history, physical examination, spirometry, asthma control test, and doctor's diagnosis

89 children, recording respiratory symptoms and spirometry at 12 and 18 years.

90 a prospective birth cohort study, performed spirometry at 8 and 16 years and IOS at 16 years of age.

91 Stockholm, Epidemiological Survey) performed spirometry at age 16 years.

92 went inspiratory and expiratory chest CT and spirometry at baseline and 5-year follow-up.

93 ricted the sample to participants with valid spirometry at two or more exams.

94 ake were randomized, and 345 (89%) completed spirometry at week 24.

95 Standard spirometry, atopy traits, blood eosinophilia, and urinar

96 We subdivided participants with normal spirometry based on respiratory-related impairment (6-mi

97 ad no specific sex association, intermediate spirometry, BDR, BHR, more significant BTS step therapy

98 ung index cases to reduce bias, and compared spirometry between 70 SZ and 46 MM/MS individuals (contr

99 had the following assessments: Feno levels, spirometry, blood samples analyzed for hemoglobin, white

100 estimating equations adjusting for childhood spirometry, body mass index, age, and sex.

101 patients with asthma were characterized with spirometry, body plethysmography, impulse oscillometry,

102 We assessed all participants with spirometry, body plethysmography, impulse oscillometry,

103 combinations of physiological tests, such as spirometry, body plethysmography, impulse oscillometry,

104 e-matched healthy control subjects underwent spirometry, body plethysmography, multiple-breath inert

105 Data on spirometry, bronchial responsiveness, respiratory sympto

106 We also measured spirometry, bronchodilator reversibility, and FeNO at fo

107 ma had positive results for all three tests (spirometry, bronchodilator reversibility, and FeNO).

108 COPD can be diagnosed early using spirometry, but spirometry use is only recommended in sy

109 rcent predicted FVC measured by clinic-based spirometry, change in percent predicted DLco, change in

110 ndardized procedures for diagnostic testing, spirometry, chest computed tomography, respiratory cultu

111 monoxide was tested and volunteers underwent spirometry, chest x-ray study, and a bronchoalveolar lav

112 oor microbiomes of patients with asthma with spirometry, clinical, and endotype parameters.

113 tives: To determine the effect of SZ-AATD on spirometry compared with a normal-risk population and to

114 Spirometry data were analyzed from 1,082 schoolchildren

115 Full montage home sleep testing and spirometry data were analyzed on 6,173 participants of t

116 ographics, clinical, and post-bronchodilator spirometry data were collected at an in-person study vis

117 Standardized spirometry data were collected at the baseline examinati

118 We included 2,250 participants who had spirometry data, 2,557 with full-lung computed tomograph

119 ged 39 years and older, white, had available spirometry data, and had complete data for phenotypes an

120 pe was related to 1989, 1995, 2001, and 2014 spirometry data.

121 determine the effect of smoking cessation on spirometry decline (n = 60) and plasma anti-neutrophil e

122 ents were more likely to have rapid-onset of spirometry decline (P = 0.05) and lower FEV1% predicted

123 smoking alone is not associated with greater spirometry decline in SZ-AATD, suggesting that cessation

124 ing or AAT concentrations, predicted greater spirometry decline.

125 with greater lung function decline, incident spirometry-defined COPD, and incident COPD-related event

126 .0011), and 15% increased hazard of incident spirometry-defined moderate-to-severe COPD (95% CI, 2-31

127 Although both LCI and spirometry discriminated health from disease, only the L

128 hough the type of ventilatory defect on best spirometry does not predict survival, failure to achieve

129 termine the association of variables on best spirometry during the first year after bilateral LT with

130 king history, 44.3 pack-years), we evaluated spirometry, dyspnea (modified Medical Research Council g

131 PI(MAX), spirometry, endurance time, and maximal diaphragm descen

132 ine recipient, donor, and surgical data; all spirometry evaluations; acute cellular rejection (ACR) e

133 GLI-defined normal spirometry, even when classified as respiratory impairme

134 ratory flow (PEF), and when stable underwent spirometry every 3 months, and completed the St. George'

135 ts (ages 17-93 years) completed 70 228 valid spirometry exams.

136 Children also underwent spirometry, exhaled nitric oxide, allergy skin testing t

137 Spirometry, FeNO, ACQ and AQLQ were significantly better

138 XIII (FXIII), NO in exhaled breath (FENO ), spirometry (FEV1 ) and eosinophil count (EOS) in 36 pati

139 and Asthma Symptom-Free Days questionnaire), spirometry (FEV1), rescue medication use, asthma deterio

140 preserved pulmonary function as assessed by spirometry (FEV1:FVC >/=0.70 and an FVC above the lower

141 Among 630 children who completed spirometry, FEV1:FVC was less than 70% in ten (2%) child

142 ective was to investigate the progression of spirometry findings over 2 years in HIV+ adolescents on

143 Lower airflow values are present by spirometry for prepubertal boys than for age-matched gir

144 Education and provision of incentive spirometry for unmonitored patient use does not result i

145 Results of spirometry, fractional exhaled nitric oxide (Feno), mann

146 g 5,100 participants with GLI-defined normal spirometry, GOLD identified respiratory impairment in 1,

147 st that among adults with GLI-defined normal spirometry, GOLD may misclassify normal phenotypes as ha

148 Relative to normal spirometry, graded associations with respiratory-related

149 Although spirometry has limited sensitivity for detecting small-a

150 Standardized measures of spirometry, hemodynamics, functional capacity, and marke

151 low BDR and BHR, impaired but non-obstructed spirometry, high symptom frequency and highest smoking p

152 Vero and pulmonary function was assessed by spirometry in 432 PLWH from the Copenhagen Comorbidity i

153 GLI established normal spirometry in 5,100 patients (50.3%), mild COPD in 669 (

154 assessed, and lung function was measured by spirometry in children at age 6-12 years.

155 a vasoocclusive crisis, and use of incentive spirometry in patients hospitalized for a vasoocclusive

156 Measurement of daily home spirometry in patients with IPF is highly clinically inf

157 uction; however, the test characteristics of spirometry in the diagnosis of asthma are not well estab

158 ever, the evidence for the role of incentive spirometry in the prevention of postoperative atelectasi

159 Overall, the phenotype of GLI-defined normal spirometry included normal adjusted mean values for dysp

160 tween exposure in different time windows and spirometry indexes were analyzed by linear regression an

161 wi, using American Thoracic Society standard spirometry, internationally validated respiratory sympto

162 uding mailed screening questionnaires before spirometry is a cost-effective way to identify undiagnos

163 Spirometry is effort dependent and only provides a singl

164 Spirometry is the cornerstone of monitoring allograft fu

165 Background: Spirometry is the most common pulmonary function test.

166 Spirometry is the reference standard for diagnosing and

167 Spirometry is today the gold standard technique for asse

168 physema on CT among patients without COPD on spirometry is warranted.

169 alpha1 antitrypsin deficiency emphysema than spirometry is, so we aimed to assess the efficacy of aug

170 Postoperative incentive spirometry (IS) is a ubiquitous practice; however, littl

171 With 3D Magnetic Resonance (MR) Spirometry, local ventilation can be assessed by MRI any

172 showed no specific atopy association, normal spirometry, low BDR, BHR and symptom severity.

173 reporting format in test-specific units for spirometry, lung volumes, and diffusing capacity that ca

174 ite the lack of between-group differences in spirometry, lung volumes, and left ventricular ejection

175 Spirometry, lung volumes, exhaled nitric oxide levels, a

176 s inherently support lung ventilation, 3D MR Spirometry may open a new way to non-invasively explore

177 eathing exercises, with or without incentive spirometry, may help counteract postoperative decreased

178 nalysed in all patients with a post-baseline spirometry measurement.

179 ch treatment group had a valid post-baseline spirometry measurement.

180 king part in the UK Biobank who had provided spirometry measurements and information on smoking.

181 had provided acceptable post-bronchodilator spirometry measurements and information on use of solid

182 ectories among participants with two or more spirometry measurements between ages 11 and 32 years.

183 particularly their impulse oscillometry and spirometry measurements, and group 2 participants also h

184 xamined the association with current asthma, spirometry measures, and related atopic traits.

185 lationships between primary cooking fuel and spirometry measures, as raw values, Global Lung Initiati

186 Spirometry measures: forced expiratory volume in 1 secon

187 ening, the following tests were carried out: spirometry, methacholine and mannitol challenge, exhaled

188 sthma and healthy control subjects underwent spirometry, methacholine challenge, and bronchoscopy, an

189 For those with normal baseline spirometry (n = 12,039), we found an excess of lung canc

190 bset of offspring by using blood samples and spirometry (n = 410 [45%]) and a questionnaire (n = 641

191 The 5-year outcome data were available for spirometry (n = 697), cough (n = 722), and dyspnea (n =

192 In a subset of patients with available spirometry (n=2540), higher RV ejection fraction and mas

193 Spirometry, occupational endotoxin exposure, and smoking

194 ur applications and respiratory symptoms and spirometry of children living in an agricultural communi

195 for 347 children at 7 y of age and measured spirometry on a subset of 279.

196 , and performed pre- and post-bronchodilator spirometry on eligible participants.

197 However, many centers monitor patients with spirometry only because of the risks and insensitivity o

198 CT (at full inspiration and expiration), and spirometry or plethysmography were performed during a 2-

199 Spirometry outcomes were compared with those of African

200 ry was highly correlated with hospital-based spirometry over time.Conclusions: The results of this fi

201 We investigated the correlation between spirometry parameters and respiratory impedance, and ass

202 Subjects with restrictive or obstructive spirometry pattern at baseline were excluded.

203 -3 times/week for >=1 hour) with restrictive spirometry pattern at follow-up (defined as a postbronch

204 were at lower risk of developing restrictive spirometry pattern over 10 years.

205 3% of participants had developed restrictive spirometry pattern.

206 al activity and the incidence of restrictive spirometry pattern.

207 omics) were found to be associated with poor spirometry performance and a lower diffusing capacity fo

208 ature vectors also presented with comparable spirometry performance, and were separable by varying de

209 Spirometry performed in the work setting should be part

210 Domiciliary spirometry permits more frequent measurement of FVC than

211 onic obstructive pulmonary disease underwent spirometry, plethysmography, diffusing capacity of carbo

212 ory biomarkers and lung function assessed by spirometry pre- and post-ART initiation.

213 of individuals with Preserved Ratio Impaired Spirometry (PRISm) will develop airflow obstruction, but

214 tegorized as having preserved ratio impaired spirometry (PRISm).

215 ndpoints were change in FVC measured by site spirometry, proportion of patients who had a more than 5

216 FEV1, measured using spirometry, provides a straightforward, widely available

217 To develop spirometry reference equations for adult Hispanic/Latino

218 linical practice, use of background-specific spirometry reference equations may provide more appropri

219 e the high burden of respiratory disease, no spirometry reference values for African children are ava

220 The home monitoring program included home spirometry, reporting of symptoms and side effects, pati

221 Spirometry, respiratory symptom tests, and flow cytometr

222 Spirometry results and modified Hoehn and Yahr disease s

223 rt that screening and supplying smokers with spirometry results improves smoking cessation rates.

224 ificant improvements in IOS outcomes but not spirometry results occurred after chronic dosing with fo

225 /or sputum neutrophils and macrophages, lung spirometry results, and concurrent asthma medications (a

226 Impulse oscillometry and spirometry results, which were used to assess dysfunctio

227 inded to HTLV-1 status, clinical records and spirometry results.

228 l activity in subjects detected with COPD by spirometry screening.

229 Current spirometry should be compared with previous tests.

230 Home spirometry showed excellent correlation with hospital-ob

231 Clinical-demographic questionnaire, spirometry, skin prick test and specific IgE were evalua

232 A clinical-demographic questionnaire, spirometry, skin prick test, and specific IgE to aeroall

233 nt, metabolic rate measurement, capnography, spirometry, sleep pattern analysis, and biometrics.

234 t, fraction of exhaled nitric oxide (Fe(NO)) spirometry, sputum induction, and gave a blood sample.

235 NO2 and after adjusting for race and season (spirometry standardized by age, height, and sex), NO2 le

236 sues that previous American Thoracic Society spirometry statements did not adequately address with re

237 current technical capabilities.Methods: This spirometry technical standards document was developed by

238 dence related to the following: training for spirometry technicians; testing posture; appropriate ref

239 born between 2003 and 2009) for whom a valid spirometry test was recorded for the child.

240 relation between the results from a standard spirometry test, forced expiratory volume in one-second

241 ere temporary residence, inability to take a spirometry test, hospital treatment of cardiovascular co

242 sthma verification algorithm on the basis of spirometry testing and a methacholine challenge test aga

243 A subgroup of 930 individuals underwent spirometry testing at age 50 years.

244 h airflow limitation (70.6%) had no previous spirometry testing or diagnosed pulmonary disease.

245 Spirometry testing was completed and the pre-bronchodila

246 Spirometry testing was used to measure lung function and

247 ning and feedback can improve the quality of spirometry testing.

248 We analyzed 3567 normal spirometry tests with available AEX values, performed on

249 cts of the performance and interpretation of spirometry that are particularly important in the workpl

250 ngs challenge the proposed cutoff values for spirometry, the order in which the lung function tests a

251 BEC donors completed spirometry to measure lung function.

252 ed validated questionnaires and administered spirometry to participants.

253 d to update the 2005 technical standards for spirometry to take full advantage of current technical c

254 We also used spirometry to test BHR to acetylcholine (PC20Ach).

255 ould not recommend the addition of incentive spirometry to the current standard of care in this resou

256 After baseline prebronchodilator spirometry, to identify the presence of airflow limitati

257 can be diagnosed early using spirometry, but spirometry use is only recommended in symptomatic smoker

258 n the definition based on pre-bronchodilator spirometry (using post-bronchodilator measurements from

259 insic skin Aging) and airflow obstruction by spirometry, using the ratio of forced expiratory volume

260 The adverse events (AEs), spirometry values, and rescue medication required for AE

261 ected by intraindividual variability in home spirometry values, which prevented application of the pr

262 ly characterized by clinical questionnaires, spirometry, volumetric inspiratory and expiratory comput

263 dicted median change in FVC measured by home spirometry was -87.7 mL (Q1-Q3 -338.1 to 148.6) in the p

264 Spirometry was also conducted on a subset.

265 in clinical care and interventional trials; spirometry was also conducted.

266 More severely impaired baseline spirometry was associated with a lower likelihood of imp

267 CO in exhaled breath at the same time as spirometry was associated with lower lung function [aver

268 Best spirometry was calculated as the average of 2 highest me

269 Best spirometry was calculated as the average of 2 highest me

270 ion, expressed as the FEV1 slope in mL/year; spirometry was done annually during follow-up for up to

271 ive parameters, significant correlation with spirometry was found with the qualitative scoring for em

272 Home-based spirometry was highly correlated with hospital-based spi

273 redicted mean change in FVC measured by site spirometry was lower in patients given pirfenidone than

274 bstruction assessed from post-bronchodilator spirometry was not associated with use of solid fuels fo

275 Prebronchodilator/postbronchodilator spirometry was performed at baseline and 6 and 12 months

276 At the end of each study week, spirometry was performed by trained physicians, and the

277 Prebronchodilator spirometry was performed for a cohort of 7-year-old Tasm

278 Spirometry was performed up to 3 times per participant (

279 Spirometry was performed using standardized methods with

280 Daily spirometry was recorded by 50 subjects for a median peri

281 In 15/16 episodes of AR2, spirometry was stable or improving in the weeks leading

282 Clinical assessment and hospital-based spirometry was undertaken at 6 and 12 months, and outcom

283 cally diverse cohort of subjects with normal spirometry, we computed by both regression and ANN model

284 s and participants unable to be tested using spirometry were excluded.

285 Only patients with COPD on spirometry were included.

286 evisions to the 2005 technical standards for spirometry were made, including the addition of factors

287 Cumulative tobacco smoking histories and spirometry were obtained at ages 18, 21, 26, 32, and 38

288 Questionnaire data, HIV status, and standard spirometry were obtained from 1,059, 933, and 749 partic

289 Anthropometry and spirometry were obtained in children aged 6 to 12 years

290 Blood sampling and spirometry were performed before and up to 48 hours afte

291 A respiratory questionnaire and standardized spirometry were performed with post-bronchodilator measu

292 PEF and spirometry were recorded in 186 cases and 160 control su

293 s (including prescreening questionnaires and spirometry); whether screening for COPD improves the del

294 re group) by use of impulse oscillometry and spirometry, which are easy to use, is meaningful given i

295 ned with blood collection, skin prick tests, spirometry with bronchodilation, and exhaled nitric oxid

296 sensitivity and AUC values when compared to spirometry with bronchodilation.

297 COPD was defined by spirometry with the 2017 Global Initiative for Chronic O

298 Lung function measurement by means of spirometry with the raised-volume thoracoabdominal compr

299 ned by the presence of airflow limitation on spirometry, yet subjects with COPD can have marked diffe

300 Spirometry z-scores were derived using the GLI-2012 pred